On Wednesday, June 13, 2007, at 2:30 pm (Eastern), the American Association for Clinical Chemistry presents an audioconference on the important issue of testing for prostate cancer.
In about 80% of men who have prostate biopsies, no tumor is found even though their PSA prostate-specific antigen) levels are elevated. This creates a dilemma for clinicians who strive to diagnose prostate cancer in its early stages, but do not want to put their patients through painful, invasive procedures that may ultimately be unnecessary. Promising new assays are becoming available that can help solve this dilemma and potentially eliminate thousands of biopsies a year. The audio conference will feature three expert speakers:
- Lynn Witherspoon, MD, Vice President and Chief Information Officer at Ochsner Medical Center in New Orleans, LA
- Robert Getzenberg, PhD, Director of Research of the James Buchanan Brady Urological Institute and Professor of Urology at the Johns Hopkins University School of Medicine in Baltimore, MD
- Leonard Marks, MD, Founding Medical Director of the Urological Sciences Research Foundation, Clinical Associate Professor in the Department of Surgery/Urology at the UCLA School of Medicine and a practicing physician in private practice in West Los Angeles, CA
Two of our speakers have recently featured in reports about prostrate cancer testing – Dr. Getzenberg in The Washington Post on April 26 and Dr. Marks in a news release issued by Gen-Probe Inc. To read these, follow the links Washington Post and Gen-Probe.
AACC invites members of the press to participate in the conference at no charge. Contact Peter Patterson at 1-800-892-1400 ext. 718 for more information. All that is needed to participate is a telephone. Registration is by site with one telephone connection per registration. Prior to the event, AACC will put the conference manual and dial-in instructions on the website at www.aacc.org.
For more information on prostate cancer testing, contact Sue Parham at AACC on 1-800-892-1400 ext. 602.